¼¼°èÀÇ °æÇÇ ¾à¹°Àü´Þ ½ÃÀå(2025-2029³â)
Global Transdermal Drug Delivery Market 2025-2029
»óǰÄÚµå : 1798127
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 228 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,511,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,617,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°æÇÇ ¾à¹°Àü´Þ ½ÃÀåÀº 2024-2029³â 26¾ï 6,600¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 5.1%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ °æÇÇÀû ¾à¹° Àü´Þ(Transdermal Drug Delivery) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ¼ºÀå¿äÀÎ, Àüü ½ÃÀå ȯ°æ¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¸¸¼ºÁúȯÀÇ È®»ê, °æÇÇ¿ë ÆÐÄ¡ Àû¿ë È®´ë, °æÇÇ ¾à¹° Àü´ÞÀ» À§ÇÑ »ýºÐÇØ¼º ¹× »ýüÀûÇÕ¼º ¼ÒÀç µîÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ 2025³â
Á¾·á ¿¬µµ 2029³â
¿¹Ãø ±â°£ 2025-2029³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ 4.6%
CAGR 5.1%
Áõ°¡¾× 26¾ï 6,600¸¸ ´Þ·¯

º» Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü¿©ÀÚµéÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î Á¶ÇÕÇÏ¿© ½Ç½ÃµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼­¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®°ú ÇÔ²² Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ªº° ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼­¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.

º» Á¶»ç´Â ÇâÈÄ ¸î ³â µ¿¾È °æÇÇ ¾à¹° Àü´Þ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ÀÌÀ¯ Áß Çϳª·Î °æÇÇÈí¼öÇü ÀǾàǰ¿¡ ´ëÇÑ °ü½É Áõ°¡¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ È°¹ßÇÑ ¼ö¿ä¿Í »ç¾÷ È®ÀåÀ» À§ÇÑ °øµ¿¿¬±¸¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå Technavio ºÐ¼®

Á¦3Àå ½ÃÀå ±¸µµ

Á¦4Àå ½ÃÀå ±Ô¸ð

Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦6Àå Á¤¼º ºÐ¼®

Á¦7Àå Five Forces ºÐ¼®

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­ : ¿ëµµº°

Á¦9Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Çüº°

Á¦10Àå ½ÃÀå ¼¼ºÐÈ­ : ±â¼úº°

Á¦11Àå °í°´ »óȲ

Á¦12Àå Áö¿ªº° »óȲ

Á¦13Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ ¹× ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦14Àå °æÀï ±¸µµ

Á¦15Àå °æÀï ºÐ¼®

Á¦16Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The transdermal drug delivery market is forecasted to grow by USD 2,666 mn during 2024-2029, accelerating at a CAGR of 5.1% during the forecast period. The report on the transdermal drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, increased applications of transdermal patches, and biodegradable and biocompatible materials for transdermal drug delivery.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20254.6%
CAGR5.1%
Incremental Value$2,666 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's transdermal drug delivery market is segmented as below:

By Application

By Type

By Technology

By Geographical Landscape

This study identifies the growing interest in transdermal medicines as one of the prime reasons driving the transdermal drug delivery market growth during the next few years. Also, robust demand for non-invasive treatment and growing focus on collaborations for business expansion will lead to sizable demand in the market.

The report on the transdermal drug delivery market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transdermal drug delivery market vendors that include 3M Co., Boehringer Ingelheim International GmbH, Croda International PLC, Hisamitsu Pharmaceutical Co. Inc., Johnson and Johnson Services Inc., Kindeva Drug Delivery L.P., Luye Pharma Group Ltd., Medherant Ltd., Novartis AG, ProSolus Inc., Purdue Pharma LP, Rusan Pharma Ltd., Sparsha Pharma International Pvt. Ltd., Teikoku Seiyaku Co. Ltd., UCB SA, and Viatris Inc.. Also, the transdermal drug delivery market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Application

9 Market Segmentation by Type

10 Market Segmentation by Technology

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â